Other
Sore Throat
0
Pipeline Programs↗
4
Active Trials↗
3
Companies Involved↗
Sore Throat is an early-stage landscape with 0 programs across 3 companies. The most active players are Boehringer Ingelheim, Pfizer, Sanofi.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
15
clinical trials
Completed9 · 60%
Recruiting2 · 13%
Not yet recruiting2 · 13%
Unknown status1 · 7%
Withdrawn1 · 7%
Clinical Trials
Trial Activity
15 trials
Sore Throat in Primary Care - a Comparison of Phenoxymethylpenicillin and No Antibiotic Treatment
Recruiting·—·Phase 4·NCT04083417·260 enrolled
the Impact of Ketamine Gargling on the Incidence of Post Intubation Sore Throat
Not yet recruiting·—·N/A·NCT06368843·80 enrolled
Effect of Clove Oil and Menthol Lozenges on Post-extubation Sore Throat
Unknown status·—·Phase 1·NCT06811051·150 enrolled
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)